Advocating on Behalf of the American Military and Defense on the War on Terror

Let us bow our head in prayer and give thanks to the hard work and amazing discovery about to change the world. Thank you God. Thank you Leukemia researchers around the world and at the University of Pennsylvania!

Original Article

In a potential breakthrough in cancer research, scientists at the University of Pennsylvania have genetically engineered patients' T cells--a type of white blood cell--to attack cancer cells in advanced cases of a common type of leukemia. Two of the three patients who received doses of the designer T cells in a clinical trial have remained cancer-free for more than a year, the researchers said. Experts not connected with the trial said the feat was important because it suggested that T cells could be tweaked to kill a range of cancers, including ones of the blood, breast and colon